Patent · US Active

Substituted azaheterocycles for the treatment of cancer

US9199962B2 · kind B2 · utility

0Cited by

2References

21Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Timo Heinrich · Groß-Umstadt, DE
Nadia Brugger · Cambridge, US
Kristopher Josephson · Wayland, US

Key dates

Filing date	Jun 11, 2012
Grant date	Dec 1, 2015
Priority date	—
Expiry date	Jun 11, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D473/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides novel substituted azaheterocyclic compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.